Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Safety and Efficacy of GK01 Autologous Tumor-reactive T Cells (TRT) in Patients With Advanced Solid Tumors

NCT06431100 is registered in ClinicalTrials.gov with Beijing Geekgene Technology Co., LTD as lead sponsor.

NCT NCT06431100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06431100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Safety and Efficacy of GK01 Autologous Tumor-reactive T Cells (TRT) in Patients With Advanced Solid Tumors
Lead sponsor
Beijing Geekgene Technology Co., LTD
Phase
Observational
Overall status
Recruiting
Start date
July 19, 2023
Completion date
November 19, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, esophageal cancer, gastric cancer, non-small cell lung cancer nsclc, triple negative breast cancer tnbc